Author: Lee, Na-Ra; Kwon, Hyun-Mi; Park, Kkothanahreum; Oh, Sangtaek; Jeong, Yong-Joo; Kim, Dong-Eun
Title: Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13 Document date: 2010_7_29
ID: 1k99yv4i_2
Snippet: Since the viral helicase has been identified as a potential target for therapy in other viruses due to its indispensability in viral genome replication (10) (11) (12) , SCV NTPase/ Helicase (nsP13), which was recently purified and characterized, was suggested as an attractive target for the development of anti-SCV agents (7) . Thus, a lot of efforts have been made to identify and test small molecule inhibitors of the SCV helicase as drug candidat.....
Document: Since the viral helicase has been identified as a potential target for therapy in other viruses due to its indispensability in viral genome replication (10) (11) (12) , SCV NTPase/ Helicase (nsP13), which was recently purified and characterized, was suggested as an attractive target for the development of anti-SCV agents (7) . Thus, a lot of efforts have been made to identify and test small molecule inhibitors of the SCV helicase as drug candidates (13) (14) (15) (16) . RNA and DNA aptamers against SCV helicase were also reported to have an inhibitory effect against nucleic acids unwinding (17, 18) . Although the tertiary structure of the SCV NTPase/Helicase has not been experimentally verified, the structure prediction of the protein was recently reported (19, 20) . SCV nsP13 has been shown to contain two separate domains, i.e. the helicase domain (Hel) and a metal-binding domain (MBD), which consists of several conserved Cys/His residues at the N-terminal (6, 19) . The SCV helicase Hel domain has been categorized into the Superfamily I helicase based on the conserved sequence motifs as shown in the Escherichia coli Rep helicase (21) .
Search related documents:
Co phrase search for related documents- attractive target and viral genome replication: 1, 2
- attractive target and viral helicase: 1, 2, 3
- drug candidate and therapy potential target: 1
- drug candidate and viral genome replication: 1
- drug candidate and viral helicase: 1
- Escherichia coli and therapy potential target: 1, 2
- Escherichia coli and viral genome replication: 1, 2, 3, 4
- Escherichia coli and viral helicase: 1
- Escherichia coli and virus therapy potential target: 1
- genome replication and therapy potential target: 1
- genome replication and viral genome replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- genome replication and viral helicase: 1, 2, 3, 4, 5, 6, 7
- helicase domain and viral genome replication: 1
- helicase domain and viral helicase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- inhibitory effect and therapy potential target: 1
- inhibitory effect and viral genome replication: 1, 2, 3, 4
- inhibitory effect and viral helicase: 1
- molecule inhibitor and viral helicase: 1
- nucleic acid and viral genome replication: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date